KNSL enters its July 23 Q2 earnings release with short sellers quietly stepping back — even as the analyst community remains split on whether a 13% monthly rally has run too far ahead of the fundamentals.
Short interest has pulled back meaningfully: at 10.9% of the free float, the position is still elevated in absolute terms, but it has fallen 7.2% over the past month — the clearest sign that bears have been reducing exposure into the stock's recent run. The borrow market echoes that retreat. Availability is comfortable at 291%, well above the 52-week floor of 180%, and cost to borrow has held below 0.5% throughout July. Neither metric points to squeeze pressure or a crowded repositioning. Options positioning reinforces the picture: the put/call ratio of 0.35 is close to its most bullish reading of the past year and only fractionally above its 20-day average, with a z-score near zero. Heading into the print, investors are not hedging aggressively.
The debate between bulls and bears is less about direction and more about degree. JP Morgan raised its target to $390 on July 20, the day before the print, maintaining a Neutral rating — acknowledging momentum while staying off-sides on conviction. Wells Fargo lifted its target to $366 in early July after downgrading the stock in late April, when it and several other firms cut targets sharply following Q1 results. The Q1 reaction was harsh: the stock fell nearly 6% the next day and shed more than 10% over the following five sessions. The bull case rests on consistent returns above 20%, disciplined underwriting, and growing investment income. Bears point to premium softening in property lines, rising competition in casualty, and the risk that reserves prove thinner than advertised. Morgan Stanley, which downgraded to Equal-Weight in April, trimmed its target further to $330 in May — a level now 6% below where KNSL traded as recently as early June — so some skepticism from bellwether names is still live heading in.
Ownership adds one notable wrinkle. Baron Capital Group holds 10.7% of shares and added 445,000 shares in Q2 — a meaningful commitment from one of the stock's highest-conviction backers. CEO Michael Kehoe, meanwhile, sold roughly $6.5 million of stock in early May at prices around $302-306, well below the current $350 level. That insider selling preceded the stock's recovery and does not, on its own, change the near-term thesis, but it is worth noting that the founder and largest individual holder chose to lighten up at lower prices rather than build. Kehoe still holds nearly 3.9% of the company outright.
The earnings print will test whether the acceleration in investment income and any stabilization in property premium trends can justify a valuation that has re-rated sharply higher — and whether the Street's cautious consensus, with a mean price target of $347, needs to be revised upward to catch a stock that has already moved past it.
See the live data behind this article on ORTEX.
Open KNSL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
